CON (“The window is closed”): In patients with cirrhosis with ascites, the clinical risks of nonselective beta-blocker outweigh the benefits and should NOT be prescribed

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)123-127
Number of pages5
JournalClinical Liver Disease
Issue number5
StatePublished - May 2018

ASJC Scopus subject areas

  • Hepatology

Cite this